We proudly announce our global Artificial Intelligence (AI) collaboration with Atomwise, resulting in a new publication in the journal Scientific Reports. The paper, “AI is
In a significant stride towards advancing pediatric cancer research, we are thrilled to announce that the state of Oregon has allocated a generous $1 million
The Children’s Cancer Therapy Development Institute (cc-TDI) proudly announces its partnership with Team KOODAC (Knock Out Oncogenic Drivers and Curing Childhood Cancer), a global interdisciplinary
We are excited to update you on entinostat, a therapy that’s traveled through cc-TDI’s development pipeline in the fight against rhabdomyosarcoma (RMS). Entinostat is a breast
Are you a PhD developmental biologist, biochemist, molecular biologist, biomedical engineer or stem cell biologist interested in changing paradigms and outcomes for cancers of children,
cc-TDI welcomed Claire Newman to cc-TDI as a Social Venture Partners Encore Fellow in August 2023. Claire’s role in Operations Scaling and Optimization includes diving
The Silicon Forest in Hillsboro, OR, January 9, 2024 – The Children’s Cancer Therapy Development Institute was awarded $100,000 in continued support of two research
As we make our final approach to the new year, we want to share a story that embodies the #givingbackchildhood spirit of cc-TDI’s mission. Meet
In August 2023, the cc-TDI team was introduced to the Bliss family, a vibrant and loving family who wanted to make a difference in the
Be part of our team, uncovering how childhood cancers work – and helping find the treatments that could go to clinical trials to improve outcomes.
We proudly announce our global Artificial Intelligence (AI) collaboration with Atomwise, resulting in a new publication in the journal Scientific Reports. The paper, “AI is
In a significant stride towards advancing pediatric cancer research, we are thrilled to announce that the state of Oregon has allocated a generous $1 million
The Children’s Cancer Therapy Development Institute (cc-TDI) proudly announces its partnership with Team KOODAC (Knock Out Oncogenic Drivers and Curing Childhood Cancer), a global interdisciplinary
We are excited to update you on entinostat, a therapy that’s traveled through cc-TDI’s development pipeline in the fight against rhabdomyosarcoma (RMS). Entinostat is a breast
Are you a PhD developmental biologist, biochemist, molecular biologist, biomedical engineer or stem cell biologist interested in changing paradigms and outcomes for cancers of children,
cc-TDI welcomed Claire Newman to cc-TDI as a Social Venture Partners Encore Fellow in August 2023. Claire’s role in Operations Scaling and Optimization includes diving
The Silicon Forest in Hillsboro, OR, January 9, 2024 – The Children’s Cancer Therapy Development Institute was awarded $100,000 in continued support of two research
As we make our final approach to the new year, we want to share a story that embodies the #givingbackchildhood spirit of cc-TDI’s mission. Meet
In August 2023, the cc-TDI team was introduced to the Bliss family, a vibrant and loving family who wanted to make a difference in the
Be part of our team, uncovering how childhood cancers work – and helping find the treatments that could go to clinical trials to improve outcomes.
EIN: 46-5759569
cc-TDI is a qualified 501(c)(3) charitable organization registered with the IRS
(consult with a CPA regarding specific tax implications)
Copyright 2023 – Children’s Cancer Therapy Development Institute